BeStock  
Stocks › Biotechnology › DNA

Ginkgo Bioworks DNA

US equityMarket cap rank #3607BiotechnologyAI medical concept stocks
$7.46 −$0.74 (-9.02%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.55 +1.21%
Open$7.93
Prev close$8.20
Day range$7.38 – $8.29
Volume2.51M
Market cap$483.59M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$27.71M-5.7% YoY
Operating profit-$43.63M+46.5% YoY
Net profit-$40.98M+49.2% YoY
Diluted EPS-$0.64+55.9% YoY
Free cash flow-$30.35M+4.0% YoY
Operating cash flow-$28.35M

Revenue, last 8 quarters

$43.8MDec '24$38.2MMar '25$39.1MJun '25$29.4MSep '25$63.4MDec '25$19.5MMar '26$20.2MJun '26$27.7MSep '26

Net profit, last 8 quarters

$-107.5MDec '24$-91.0MMar '25$-60.3MJun '25$-80.8MSep '25$-80.8MDec '25$-82.6MMar '26$-46.7MJun '26$-41.0MSep '26

Diluted EPS by quarter

-2.00Dec '24-1.68Mar '25-1.10Jun '25-1.45Sep '25-1.42Dec '25-1.39Mar '26-0.75Jun '26-0.64Sep '26

Free cash flow by quarter

$-56.1MDec '24$-59.1MMar '25$-40.3MJun '25$-31.6MSep '25$-47.7MDec '25$-48.6MMar '26$-46.9MJun '26$-30.3MSep '26

Annual revenue

$76.7MFY20$313.8MFY21$477.7MFY22$251.5MFY23$227.0MFY24$170.2MFY25

Profitability & balance sheet

Gross margin69.8%
Operating margin-202.5%
Net margin-192.0%
Return on equity-52.7%
Return on assets-23.5%
Return on invested capital-30.0%
Current ratio4.72
Liabilities / assets58.4%
Cash & investments$285.36M
Total debt$397.20M
Net cash (debt)-$111.84M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $27.71M $20.16M $19.47M $170.16M $63.41M
Total Operating Revenue $27.71M $20.16M $19.47M $170.16M $63.41M
Cost of Revenue $1.81M $1.72M $3.10M $46.97M $32.88M
Gross Profit $25.91M $18.44M $16.38M $123.18M $30.53M
Operating Expense $69.54M $76.99M $87.75M $427.06M $121.73M
Selling and Admin Expenses $28.59M $30.78M $37.83M $183.29M $71.60M
-General & Admin Expense $28.59M $30.78M $37.83M $183.29M $71.60M
Research & Development $40.95M $46.21M $49.92M $243.77M $50.13M
Operating Profit -$43.63M -$58.55M -$71.37M -$303.88M -$91.19M
Net Non-Operating Interest Income (Expense) $3.06M $3.23M $3.60M $22.62M $4.71M
Non-Operating Interest Income $3.06M $3.23M $3.60M $22.62M $4.71M
Other Income (Expense) -$682,000.00 -$1.88M -$8.36M -$32.34M -$17.07M
Gain on Sale of Security $4.74M $1.99M -$1.21M -$16.41M -$18.02M
Earnings from Equity Interest -$2.01M -$4.67M – $0.00 $0.00
Special Income (Charges) -$5.02M $0.00 $0.00 -$11.40M -$801,000.00
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $0.00 $11.40M $2.65M
-Less:Write Off $5.02M $0.00 $0.00 – –
Other Non-Operating Income (Expenses) $1.61M $809,000.00 -$7.15M -$4.53M $1.75M
Pretax Profit -$41.26M -$57.19M -$76.14M -$313.60M -$103.55M
Tax -$271,000.00 $128,000.00 -$80,000.00 -$837,000.00 -$643,000.00
Net Profit -$40.98M -$46.71M -$82.59M -$312.76M -$80.75M
Profit from Continuing Operations -$40.98M -$57.32M -$76.06M -$312.76M -$102.91M
Net Income from Discontinuous Operations $0.00 $10.61M -$6.53M – –
Net Income to Parent Company -$40.98M -$46.71M -$82.59M -$312.76M -$80.75M
Net Income to Common Stockholders -$40.98M -$46.71M -$82.59M -$312.76M -$80.75M
Basic EPS -$0.64 -$0.75 -$1.39 -$5.64 -$1.42
Diluted EPS -$0.64 -$0.75 -$1.39 -$5.64 -$1.42
Non-Operating Interest Expense – – – $0.00 –
-Less:Impairment of Capital Assets – – – $0.00 $0.00
-Gain on Sale Of Business – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $944.45M $990.05M $1.03B $1.12B $1.12B
Total Current Assets $310.84M $332.54M $409.96M $471.84M $471.84M
Cash and Cash Equivalents & Short-Term Investments $285.36M $302.16M $373.46M $422.62M $422.62M
-Cash and Cash Equivalents $84.50M $84.54M $143.86M $167.20M $167.20M
-Short Term Investments $200.86M $217.63M $229.59M $255.42M $255.42M
Receivables $11.49M $13.01M $20.27M $24.26M $24.26M
-Accounts Receivable $11.49M $13.01M $19.82M $24.03M $24.03M
-Due from Related Parties Current $0.00 $0.00 $454,000.00 $229,000.00 $229,000.00
Other Current Assets $14.00M $17.36M $16.23M $24.96M $24.96M
Total Non-Current Assets $633.61M $657.51M $623.12M $647.86M $647.86M
Net PPE $493.84M $504.85M $516.82M $528.70M $528.70M
-Gross PPE $698.47M $702.43M $706.20M $719.30M $719.30M
-Accumulated Depreciation -$204.63M -$197.58M -$189.38M -$190.60M -$190.60M
Investments and Advances $14.37M $22.27M $14.60M $14.88M $14.88M
-Available for Sale Securities $8.76M $12.47M $12.41M $12.69M $12.69M
-Long Term Equity Investment $5.61M $7.62M – – –
Financial Assets $190,000.00 $119,000.00 $104,000.00 $191,000.00 $191,000.00
Goodwill and Other Intangible Assets $39.73M $44.39M $48.86M $56.92M $56.92M
-Other Intangible Assets $39.73M $44.39M $48.86M $56.92M $56.92M
Other Non-Current Assets $85.48M $85.89M $42.73M $47.17M $47.17M
Total Liabilities $551.82M $569.76M $589.92M $611.11M $611.11M
Total Current Liabilities $65.85M $72.74M $79.60M $95.97M $95.97M
Payables $7.18M $9.58M $16.31M $10.57M $10.57M
-Accounts Payable $7.18M $9.58M $16.31M $10.57M $10.57M
Current Accrued Expenses $52.28M $49.95M $48.38M $10.50M $10.50M
Current Deferred Liabilities $6.39M $13.21M $14.91M $19.98M $19.98M
Total Non-Current Liabilities $485.97M $497.02M $510.33M $515.14M $515.14M
Long Term Debt and Capital Lease Obligation $397.20M $404.11M $410.70M $417.08M $417.08M
-Long Term Capital Lease Obligation $397.20M $404.11M $410.70M $417.08M $417.08M
Non-Current Deferred Liabilities $71.98M $76.54M $77.90M $75.18M $75.18M
Other Non-Current Liabilities $16.79M $16.37M $21.73M $22.88M $22.88M
Total Equity $392.64M $420.28M $443.15M $508.59M $508.59M
Stockholders' Equity $392.64M $420.28M $443.15M $508.59M $508.59M
Capital Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Common Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $6.71B $6.70B $6.67B $6.66B $6.66B
Retained Earnings -$6.32B -$6.28B -$6.23B -$6.15B -$6.15B
Gains/Losses Not Affecting Retained Earnings $115,000.00 $950,000.00 $1.19M $1.85M $1.85M
Short-Term Debt and Capital Lease Obligation – – – $22.81M $22.81M
-Current Capital Lease Obligation – – – $22.81M $22.81M
Other Current Liabilities – – – $27.05M $27.05M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$28.35M -$44.27M -$46.69M -$171.06M -$47.68M
Net cash flow from continuing operations -$28.35M -$42.17M -$46.43M -$171.06M -$59.51M
Net Income from Continuing Operations -$40.98M -$57.32M -$76.06M -$312.76M -$102.91M
Gain/Loss from Continuing Operations $287,000.00 -$1.99M $1.21M $16.41M $16.14M
Depreciation & Depletion & Amortization $12.04M $12.32M $12.80M $58.99M $15.30M
Other Non-Cash Items $7.41M $10.60M $13.81M $33.60M $8.09M
Change in Working Capital -$14.94M -$13.15M -$14.18M -$44.09M -$24.19M
-Change in Receivables $1.50M $3.71M -$242,000.00 -$1.47M -$2.92M
-Change in Prepaid Assets $3.99M -$6.71M $5.93M -$5.25M -$4.47M
-Change in Payables and Accrued Expense -$6.66M $3.94M -$11.60M $7.38M -$10.05M
-Change in Other Current Assets $155,000.00 $48,000.00 $94,000.00 $4.11M $334,000.00
-Change in Other Current Liabilities -$5.12M -$11.11M -$5.75M -$16.47M -$2.14M
-Change In Other Working Capital -$8.81M -$3.03M -$2.61M -$32.39M -$4.95M
Cash Flow from Discontinued Operating Activities $0.00 – – – –
Net cash flow from investing -$24.10M $11.09M $23.13M -$240.29M $95.10M
Net Cash Flow from Continuing Investing Activities -$24.10M $11.09M $23.13M -$240.29M $95.10M
Net PPE Purchase and Sale -$2.00M -$2.62M -$1.93M -$7.09M $569,000.00
Net Investment Purchase and Sale -$22.57M $13.71M $25.02M -$233.25M $94.99M
Net Other Investing Changes $464,000.00 $0.00 $48,000.00 $50,000.00 -$461,000.00
Financing Cash Flow $6.50M $16.49M -$19,000.00 $17.78M $8.14M
Net Cash Flow from Continuing Financing Activities $6.50M $16.49M -$19,000.00 $17.78M $8.14M
Net Issuance Payments Of Debt $0.00 $0.00 -$19,000.00 -$354,000.00 -$25,000.00
Net Other Financing Charges -$17.29M – – -$1.34M -$985,000.00
Ending Cash Balance $126.08M $172.02M $188.67M $212.37M $212.37M
Net Change in Cash -$45.95M -$16.70M -$23.57M -$393.57M $55.56M
Beginning Cash Balance $172.02M $188.67M $212.37M $605.74M $156.96M
Effect of Exchange Rate Changes $6,000.00 $43,000.00 -$129,000.00 $201,000.00 -$152,000.00
Free Cash Flow -$30.35M -$46.89M -$48.62M -$178.72M -$47.68M
Deferred Tax – – – -$1.36M –
Net Business Purchase and Sale – – – $0.00 $0.00
Net Common Stock Issuance – – – $19.47M $9.15M
Proceeds from Stock Option Exercised – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on DNA.

Sign in to join the discussion.

Scroll to Top